Inventor
NOVOBRANTSEVA TATIANA
US29 patents
⚠️ This page may combine multiple inventors who share the name “NOVOBRANTSEVA TATIANA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
16 patentsUS9422562B2Aug 23, 2016
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
ALNYLAM PHARMACEUTICALS INC8 citations83
US7871985B2Jan 18, 2011
Compositions and methods for inhibiting expression of factor VII gene
ALNYLAM PHARMACEUTICALS INC5 citations74
US10472628B2Nov 12, 2019
Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
ALNYLAM PHARMACEUTICALS INC1 citations73
US7759320B2Jul 20, 2010
Compositions and methods for inhibiting expression of a gene from the Ebola
ALNYLAM PHARMACEUTICALS INC6 citations73
US10745704B2Aug 18, 2020
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
ALNYLAM PHARMACEUTICALS INC3 citations72
US9868950B2Jan 16, 2018
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
ALNYLAM PHARMACEUTICALS INC1 citations63
US9062310B2Jun 23, 2015
Compositions and methods for inhibiting expression of factor VII gene
ALNYLAM PHARMACEUTICALS INC1 citations63
US11884919B2Jan 30, 2024
Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene
ALNYLAM PHARMACEUTICALS INC0 citations62
US11149273B2Oct 19, 2021
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
ALNYLAM PHARMACEUTICALS INC0 citations62
US8735369B2May 27, 2014
Compositions and methods for inhibiting expression of a gene from the Ebola virus
ALNYLAM PHARMACEUTICALS INC1 citations62
US10669303B2Jun 2, 2020
Compositions and methods directed to treating liver fibrosis
ALNYLAM PHARMACEUTICALS INC0 citations52
US9206421B2Dec 8, 2015
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
ALNYLAM PHARMACEUTICALS INC0 citations52
US9932593B2Apr 3, 2018
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
ALNYLAM PHARMACEUTICALS INC0 citations51
US9187516B2Nov 17, 2015
Compositions and methods for inhibiting expression of a gene from the Ebola virus
ALNYLAM PHARMACEUTICALS INC0 citations51
US8354390B2Jan 15, 2013
Compositions and methods for inhibiting expression of a gene from the ebola virus
ALNYLAM PHARMACEUTICALS INC0 citations51
US7973020B2Jul 5, 2011
Compositions and methods for inhibiting expression of a gene from the ebola virus
ALNYLAM PHARMACEUTICALS INC0 citations51
DE FOUGEROLLES ANTONIN
7 patentsUS8546554B2Oct 1, 2013
Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
DE FOUGEROLLES ANTONIN25 citations92
US8664193B2Mar 4, 2014
Compositions and methods for inhibiting expression of factor VII gene
DE FOUGEROLLES ANTONIN1 citations62
US8334273B2Dec 18, 2012
Compositions and methods for inhibiting expression of factor VII gene
DE FOUGEROLLES ANTONIN1 citations62
US8227188B2Jul 24, 2012
Enhancement of influenza gene expression
DE FOUGEROLLES ANTONIN4 citations59
US9029338B2May 12, 2015
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
DE FOUGEROLLES ANTONIN1 citations51
US8912316B2Dec 16, 2014
Compositions and methods for inhibiting expression of CD45 gene
DE FOUGEROLLES ANTONIN0 citations51
US8288525B2Oct 16, 2012
Compositions and methods for inhibiting expression of CD45 gene
DE FOUGEROLLES ANTONIN1 citations51